Nasdaq: ENSC

Ensysce Biosciences, Inc. (ENSC)

Ensysce Biosciences, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker ENSC. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
ENSC
Exchange
Nasdaq
SEC CIK
1716947
Official filings
SEC EDGAR

Research ENSC

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Ensysce Biosciences, Inc.'s stock ticker?

Ensysce Biosciences, Inc. trades under the ticker symbol ENSC on Nasdaq. Its SEC Central Index Key (CIK) is 1716947.

Where can I read Ensysce Biosciences, Inc.'s SEC filings?

The ENSC SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Ensysce Biosciences, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze ENSC's financial statements?

The ENSC Financials page shows Ensysce Biosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does ENSC compare with its peers and the market?

The ENSC Peer Comparison page lines Ensysce Biosciences, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.